Tectonic Therapeutic develops protein and antibody drugs that act on G protein coupled receptors, led by a candidate for pulmonary hypertension. It last closed at $20.08 on Nov 17, down 4.29% on the day. Over the past 90 days StreetAlpha recorded 1 whale options trade in TECX, 100% of them bullish and 0% bearish.
Only 1 firm rated TECX in the past 90 days, not enough for a consensus
Average 12-month target
$26.00
▲ 29.5% upside
Based on 1 analyst who set a price target on TECX in the past 90 days. The average target is $26.00, with a high of $26.00 and a low of $26.00, compared with the last close of $20.08.
Low $26.00Avg $26.00High $26.00
Blue marker: last close $20.08
Highest target$26.00
Average target$26.00
Lowest target$26.00
Latest rating changes
UBSInitiated
Oct 12Hold$26
Wells FargoMaintained
Aug 7Buy$93
Raymond JamesUpgrade
May 26Buy$76 → $81
StifelInitiated
Apr 14Buy$75
Raymond JamesReinstated
Jun 11Buy$76
Date
Firm
Action
Rating
Price target
Oct 12
UBS
Initiated
Hold
$26
Aug 7
Wells Fargo
Maintained
Buy
$93
May 26
Raymond James
Upgrade
Buy
$76 → $81
Apr 14
Stifel
Initiated
Buy
$75
Jun 11
Raymond James
Reinstated
Buy
$76
Loading…
Technical Analysis
TECX · as of the Nov 17 close · updated after every close
Downtrend
The stock is 2% below its 20 day and 14% below its 50 day average. It is 40% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 41). The nearest support is the Pivot S1 at $19.54, and the nearest resistance the Pivot at $20.39.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 6.4%/day
Key levels
$39.5352 week high+96.9%
$28.13200 day average+40.1%
$27.93100 day average+39.1%
$22.9050 day average+14.0%
$21.44Swing high (Oct 29)+6.8%
$20.93Pivot R1+4.2%
$20.5720 day average+2.4%
$20.39Pivot+1.5%
$20.08Last close
$19.54Pivot S1−2.7%
$18.54Swing low (Nov 2)−7.7%
$16.7752 week low−16.5%
Indicators
RSI (14)
40.94
Middle of its range
Neutral
MACD
-0.54
Above its signal line
Bullish
Stochastic
52.0
Middle of its range
Neutral
ADX (14)
30.8
Trending down
Williams %R
-63.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-20.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+5.8%
Change over 10 sessions
Bullish
ATR (14)
$1.28
Typical daily range, 6.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 17.1%/day
Key levels
$39.5352 week high+96.9%
$28.13200 day average+40.1%
$27.93100 day average+39.1%
$22.9050 day average+14.0%
$21.44Swing high (Oct 29)+6.8%
$20.93Pivot R1+4.2%
$20.5720 day average+2.4%
$20.39Pivot+1.5%
$20.08Last close
$19.54Pivot S1−2.7%
$18.54Swing low (Nov 2)−7.7%
$16.7752 week low−16.5%
Indicators
RSI (14)
37.59
Weak, oversold below 30
Neutral
MACD
-2.48
Below its signal line
Bearish
Stochastic
10.3
Near the bottom of its range
Oversold
ADX (14)
21.9
Weak trend
Williams %R
-92.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-89.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−30.9%
Change over 10 sessions
Bearish
ATR (14)
$3.44
Typical daily range, 17.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TECX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TECX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow TECX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TECX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TECX is in one of them and how their past TECX trades turned out.
Tectonic Therapeutic is a biotechnology company based in Watertown, Massachusetts. It develops therapeutic proteins and antibodies that act on G protein coupled receptors, a family of cell surface molecules that help control many body functions. Its lead candidate, TX45, is a relaxin based molecule being tested for pulmonary hypertension linked to heart and lung disease. The company's work is aimed at patients with serious conditions where treatment options are limited.